Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2004 Filed Feb 19, 2004 19:59 UTC
SATO VICKI LPresident
Exercise / conversionStock Option · Derivative 2,691 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0000875320-04-000008 · edgar.xml · derivative · entry 4

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,201,809

Underlying: Common Stock · 2,691 shares

Expires 2004-12-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan, vesting quarterly over 5 years from 12/8/1994.

Read SEC document
February 18, 2004 Filed Feb 19, 2004 19:59 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $11.05 $41,990.00
Disclosure

SEC source: 0000875320-04-000008 · edgar.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,608

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
February 18, 2004 Filed Feb 19, 2004 19:59 UTC
SATO VICKI LPresident
Exercise / conversionCommon Stock 2,691 $6.00 $16,146.00
Disclosure

SEC source: 0000875320-04-000008 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 11, 2004 Filed Feb 12, 2004 19:30 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $10.11 $38,418.00
Disclosure

SEC source: 0000875320-04-000007 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,717

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
February 04, 2004 Filed Feb 5, 2004 19:07 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $9.60 $36,480.00
Disclosure

SEC source: 0000875320-04-000006 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,517

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
January 28, 2004 Filed Jan 29, 2004 20:19 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $10.08 $38,304.00
Disclosure

SEC source: 0000875320-04-000005 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,317

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
January 21, 2004 Filed Jan 22, 2004 16:19 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $9.98 $37,924.00
Disclosure

SEC source: 0000875320-04-000004 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,117

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
January 14, 2004 Filed Jan 15, 2004 20:28 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $9.62 $36,556.00
Disclosure

SEC source: 0000875320-04-000003 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,917

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
January 07, 2004 Filed Jan 8, 2004 18:00 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $10.07 $38,266.00
Disclosure

SEC source: 0000875320-04-000002 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,717

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 31, 2003 Filed Jan 5, 2004 16:19 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $10.19 $38,722.00
Disclosure

SEC source: 0000875320-04-000001 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,517

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 24, 2003 Filed Dec 29, 2003 15:23 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $9.68 $36,784.00
Disclosure

SEC source: 0000875320-03-000064 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,317

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 17, 2003 Filed Dec 18, 2003 18:30 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $9.02 $34,276.00
Disclosure

SEC source: 0000875320-03-000063 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,117

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 17, 2003 Filed Mar 19, 2004 20:13 UTC
SMITH IAN FSVP & CFO
GrantCommon Stock · Derivative 21,600 $0.00 Strike: $9.69 $0.00
Disclosure

SEC source: 0000875320-04-000022 · edgar.xml · derivative · entry 3

SMITH IAN F · CIK 0001197032 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,391

Underlying: Common Stock · 14,400 shares

Expires 2014-03-16

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 03/17/2004.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:14 UTC
ALAM JOHN JSVP, Drug Eval. & Appr.
GrantStock Option · Derivative 14,400 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000053 · edgar.xml · derivative · entry 3

ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,645

Underlying: Common Stock · 14,400 shares

Expires 2013-12-10

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:14 UTC
ALAM JOHN JSVP, Drug Eval. & Appr.
GrantCommon Stock 1,920 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000053 · edgar.xml · nonDerivative · entry 1

ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,454

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:16 UTC
BOGER KENNETH SSVP & General Counsel
GrantStock Option · Derivative 14,400 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000054 · edgar.xml · derivative · entry 4

BOGER KENNETH S · CIK 0001046336 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,695

Underlying: Common Stock · 14,400 shares

Expires 2013-12-10

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:16 UTC
BOGER KENNETH SSVP & General Counsel
GrantCommon Stock 1,920 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000054 · edgar.xml · nonDerivative · entry 1

BOGER KENNETH S · CIK 0001046336 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,920

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:17 UTC
BOGER JOSHUA SDirector · Chairman & CEO
GrantStock Option · Derivative 42,000 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000055 · edgar.xml · derivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,625,223

Underlying: Common Stock · 42,000 shares

Expires 2013-12-10

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:17 UTC
BOGER JOSHUA SDirector · Chairman & CEO
GrantCommon Stock 5,600 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000055 · edgar.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 866,577

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:18 UTC
BRUM LYNNE HVP, Corp. Comm.&Financial Plan
GrantStock Option · Derivative 6,000 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000056 · edgar.xml · derivative · entry 4

BRUM LYNNE H · CIK 0001197017 · VP, Corp. Comm.&Financial Plan

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,324

Underlying: Common stock · 6,000 shares

Expires 2013-12-10

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:18 UTC
BRUM LYNNE HVP, Corp. Comm.&Financial Plan
GrantCommon Stock 800 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000056 · edgar.xml · nonDerivative · entry 1

BRUM LYNNE H · CIK 0001197017 · VP, Corp. Comm.&Financial Plan

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,021

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:21 UTC
COLES N ANTHONYSVP, Comm. Ops.
GrantStock Option · Derivative 14,400 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000057 · edgar.xml · derivative · entry 3

COLES N ANTHONY · CIK 0001197018 · SVP, Comm. Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,178

Underlying: Common Stock · 14,400 shares

Expires 2013-12-11

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:21 UTC
COLES N ANTHONYSVP, Comm. Ops.
GrantCommon Stock 1,920 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000057 · edgar.xml · nonDerivative · entry 1

COLES N ANTHONY · CIK 0001197018 · SVP, Comm. Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,920

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:22 UTC
SATO VICKI LPresident
GrantCommon Stock · Derivative 30,000 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000058 · edgar.xml · derivative · entry 3

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,204,500

Underlying: Common Stock · 30,000 shares

Expires 2013-12-11

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:22 UTC
SATO VICKI LPresident
GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000058 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,917

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:23 UTC
BUCHANAN IAIN P MVP, European Operations
GrantCommon Stock · Derivative 8,184 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000059 · edgar.xml · derivative · entry 2

BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,139

Underlying: Commmon Stock · 8,184 shares

Expires 2013-12-10

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:23 UTC
BUCHANAN IAIN P MVP, European Operations
GrantCommon Stock 1,091 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000059 · edgar.xml · nonDerivative · entry 1

BUCHANAN IAIN P M · CIK 0001197027 · VP, European Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,094

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:25 UTC GrantCommon Stock · Derivative 514 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000060 · edgar.xml · derivative · entry 3

POWER JOHANNA MESSINA · CIK 0001197030 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,515

Underlying: Common Stock · 514 shares

Expires 2013-12-10

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:25 UTC GrantCommon Stock 101 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000060 · edgar.xml · nonDerivative · entry 1

POWER JOHANNA MESSINA · CIK 0001197030 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:27 UTC
MUELLER PETERCSO & SVP Drug Discovery
GrantCommon Stock · Derivative 14,400 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000062 · edgar.xml · derivative · entry 2

MUELLER PETER · CIK 0001256126 · CSO & SVP Drug Discovery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,400

Underlying: Common Stock · 14,400 shares

Expires 2013-12-11

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:27 UTC
MUELLER PETERCSO & SVP Drug Discovery
GrantCommon Stock 1,920 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000062 · edgar.xml · nonDerivative · entry 1

MUELLER PETER · CIK 0001256126 · CSO & SVP Drug Discovery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,920

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:26 UTC
SMITH IAN FSVP & CFO
GrantCommon Stock · Derivative 14,400 $0.00 Strike: $9.07 $0.00
Disclosure

SEC source: 0000875320-03-000061 · edgar.xml · derivative · entry 3

SMITH IAN F · CIK 0001197032 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,791

Underlying: Common Stock · 14,400 shares

Expires 2013-12-10

F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments frm 12/11/2003.

Read SEC document
December 11, 2003 Filed Dec 15, 2003 21:26 UTC
SMITH IAN FSVP & CFO
GrantCommon Stock 1,920 $0.00 $0.00
Disclosure

SEC source: 0000875320-03-000061 · edgar.xml · nonDerivative · entry 1

SMITH IAN F · CIK 0001197032 · SVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,920

F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting in 4 equal annual installments from 12/11/2003.

Read SEC document
December 10, 2003 Filed Dec 11, 2003 16:23 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $8.94 $33,972.00
Disclosure

SEC source: 0000875320-03-000052 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,917

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 03, 2003 Filed Dec 4, 2003 20:43 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $9.16 $34,808.00
Disclosure

SEC source: 0000875320-03-000051 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,771

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
November 26, 2003 Filed Dec 1, 2003 15:13 UTC
SATO VICKI LPresident
Exercise / conversionStock Option · Derivative 42,909 $0.00 Strike: $7.88 $0.00
Disclosure

SEC source: 0000875320-03-000050 · edgar.xml · derivative · entry 6

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,174,500

Underlying: Common Stock · 42,909 shares

Expires 2003-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 12/01/1993.

Read SEC document
November 26, 2003 Filed Dec 1, 2003 15:13 UTC
SATO VICKI LPresident
Exercise / conversionStock Option · Derivative 3,800 $0.00 Strike: $7.88 $0.00
Disclosure

SEC source: 0000875320-03-000050 · edgar.xml · derivative · entry 5

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,217,409

Underlying: Common Stock · 3,800 shares

Expires 2003-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 12/01/1993.

Read SEC document
November 26, 2003 Filed Dec 1, 2003 15:13 UTC
SATO VICKI LPresident
Exercise / conversionCommon Stock 42,909 $7.88 $338,122.92
Disclosure

SEC source: 0000875320-03-000050 · edgar.xml · nonDerivative · entry 3

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,517

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 26, 2003 Filed Dec 1, 2003 15:13 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $8.93 $33,934.00
Disclosure

SEC source: 0000875320-03-000050 · edgar.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,608

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
November 26, 2003 Filed Dec 1, 2003 15:13 UTC
SATO VICKI LPresident
Exercise / conversionCommon Stock 3,800 $7.88 $29,944.00
Disclosure

SEC source: 0000875320-03-000050 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 19, 2003 Filed Nov 20, 2003 17:13 UTC
SATO VICKI LPresident
Exercise / conversionStock Option · Derivative 3,800 $8.94 Strike: $7.88 $33,972.00
Disclosure

SEC source: 0000875320-03-000049 · edgar.xml · derivative · entry 4

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,221,209

Underlying: Common Stock · 3,800 shares

Expires 2003-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 12/01/1993.

Read SEC document
November 19, 2003 Filed Nov 20, 2003 17:13 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $8.94 $33,972.00
Disclosure

SEC source: 0000875320-03-000049 · edgar.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,608

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document
November 19, 2003 Filed Nov 20, 2003 17:13 UTC
SATO VICKI LPresident
Exercise / conversionCommon Stock 3,800 $7.88 $29,944.00
Disclosure

SEC source: 0000875320-03-000049 · edgar.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 17, 2003 Filed Nov 17, 2003 17:24 UTC
BOGER KENNETH SSVP & General Counsel
PurchaseCommon Stock 5,360 $8.87 $47,543.20
Disclosure

SEC source: 0000875320-03-000048 · edgar.xml · nonDerivative · entry 1

BOGER KENNETH S · CIK 0001046336 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,000

Read SEC document
November 13, 2003 Filed Nov 14, 2003 14:39 UTC PurchaseCommon Stock 35,142 $8.23 $289,218.66
Disclosure

SEC source: 0000875320-03-000047 · edgar.xml · nonDerivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,487

Read SEC document
November 12, 2003 Filed Nov 12, 2003 20:55 UTC PurchaseCommon Stock 10,000 $8.28 $82,800.00
Disclosure

SEC source: 0000875320-03-000044 · edgar.xml · nonDerivative · entry 2

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,000

Read SEC document
November 12, 2003 Filed Nov 12, 2003 20:55 UTC PurchaseCommon Stock 10,000 $8.28 $82,800.00
Disclosure

SEC source: 0000875320-03-000044 · edgar.xml · nonDerivative · entry 1

SANDERS CHARLES A · CIK 0001022936 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Read SEC document
November 12, 2003 Filed Nov 13, 2003 15:48 UTC PurchaseCommon Stock 67,345 $8.21 $552,902.45
Disclosure

SEC source: 0000875320-03-000045 · edgar.xml · nonDerivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,345

Read SEC document
November 12, 2003 Filed Nov 13, 2003 19:08 UTC
SATO VICKI LPresident
Exercise / conversionStock Option · Derivative 3,800 $8.16 Strike: $7.88 $31,008.00
Disclosure

SEC source: 0000875320-03-000046 · edgar.xml · derivative · entry 4

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,225,009

Underlying: Common Stock · 3,800 shares

Expires 2003-11-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Right to buy under 1991 Stock and Option Plan, vesting in 20 equal quarterly installments from 12/01/1993.

Read SEC document
November 12, 2003 Filed Nov 13, 2003 19:08 UTC
SATO VICKI LPresident
SaleCommon Stock 3,800 $8.16 $31,008.00
Disclosure

SEC source: 0000875320-03-000046 · edgar.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,608

F1 · kind: Transaction made pursuant to Dr. Sato's company approved trading plan established under Rule 10b5-1.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.